- Home
- VATE vs RFL Comparison
VATE vs RFL Comparison
Compare VATE & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- RFL
- Stock Information
- Founded
- VATE 1994
- RFL 2017
- Country
- VATE United States
- RFL United States
- Employees
- VATE N/A
- RFL N/A
- Industry
- VATE Metal Fabrications
- RFL Real Estate
- Sector
- VATE Industrials
- RFL Finance
- Exchange
- VATE Nasdaq
- RFL Nasdaq
- Market Cap
- VATE 49.2M
- RFL 48.4M
- IPO Year
- VATE 1996
- RFL N/A
- Fundamental
- Price
- VATE $3.47
- RFL $2.00
- Analyst Decision
- VATE
- RFL
- Analyst Count
- VATE 0
- RFL 0
- Target Price
- VATE N/A
- RFL N/A
- AVG Volume (30 Days)
- VATE 91.3K
- RFL 47.3K
- Earning Date
- VATE 11-07-2024
- RFL 10-28-2024
- Dividend Yield
- VATE N/A
- RFL N/A
- EPS Growth
- VATE N/A
- RFL N/A
- EPS
- VATE N/A
- RFL N/A
- Revenue
- VATE $1,364,600,000.00
- RFL $540,000.00
- Revenue This Year
- VATE N/A
- RFL N/A
- Revenue Next Year
- VATE N/A
- RFL N/A
- P/E Ratio
- VATE N/A
- RFL N/A
- Revenue Growth
- VATE N/A
- RFL 92.86
- 52 Week Low
- VATE $3.25
- RFL $1.29
- 52 Week High
- VATE $15.60
- RFL $2.14
- Technical
- Relative Strength Index (RSI)
- VATE 37.74
- RFL 74.68
- Support Level
- VATE $3.25
- RFL $1.65
- Resistance Level
- VATE $4.16
- RFL $1.94
- Average True Range (ATR)
- VATE 0.23
- RFL 0.10
- MACD
- VATE -0.02
- RFL 0.02
- Stochastic Oscillator
- VATE 22.87
- RFL 100.00
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.